← FDA Drug Approvals (Drugs@FDA)
FOSAPREPITANT DIMEGLUMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PRAXGEN · Approved 2021-10-04
Drug application
- FDA Application #
ANDA213199- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FOSAPREPITANT DIMEGLUMINE
- Generic name
- Fosaprepitant Dimeglumine
- Active ingredients
- FOSAPREPITANT DIMEGLUMINE
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- PRAXGEN
- First approval
- 2021-10-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown